US20090056723A1 - Ultrasonically Detectable Intrauterine System and a Method for Enhancing Ultrasound Detection - Google Patents

Ultrasonically Detectable Intrauterine System and a Method for Enhancing Ultrasound Detection Download PDF

Info

Publication number
US20090056723A1
US20090056723A1 US11/887,901 US88790106A US2009056723A1 US 20090056723 A1 US20090056723 A1 US 20090056723A1 US 88790106 A US88790106 A US 88790106A US 2009056723 A1 US2009056723 A1 US 2009056723A1
Authority
US
United States
Prior art keywords
ius
intrauterine system
metal
vertical arm
ultrasound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/887,901
Other languages
English (en)
Inventor
Taina Tjader
Sara Heinonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Bayer Schering Pharma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34508050&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20090056723(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Oy filed Critical Bayer Schering Pharma Oy
Assigned to BAYER SCHERING PHARMA OY reassignment BAYER SCHERING PHARMA OY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEINONEN, SARA, TJADER, TAINA
Publication of US20090056723A1 publication Critical patent/US20090056723A1/en
Assigned to BAYER OY reassignment BAYER OY CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: BAYER SCHERING PHARMA OY
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A61F6/144—Wirelike structures, e.g. loops, rings, spirals with T-configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
    • A61B8/0841—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48—Diagnostic techniques
    • A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time

Definitions

  • the present invention relates to ultrasonically detectable intrauterine systems and to a method for enhancing ultrasound detection of these systems.
  • the intrauterine systems commonly known as IUS's
  • IUS's have long been known and they have been constructed in numerous shapes and sizes and of various materials.
  • the IUS's consist normally of a plastic frame having the shape of the letter T or 7 , although the shapes of letters S and ⁇ are also possible.
  • the IUS's which contain drugs can be used to administer these drugs locally to the uterus at a controlled release rate over a prolonged period of time.
  • the medicated IUS's which have found considerable acceptance in contraception and hormonal treatment can be divided into copper and hormonal devices.
  • a copper IUD Intra Uterine Device
  • a hormone containing elastomeric capsule is placed on the vertical stem.
  • the capsule may be coated by an elastomer or polymer membrane which controls drug release from the elastomer-hormone capsule.
  • Monofilament removal threads, used for IUS removal after the period of use, are tied to the loop at the end of the vertical stem.
  • IUS's Undesirable complications that have been associated with the use of IUS's are infection, bleeding, uterine perforation, cervical laceration, septic abortion, ectopic pregnancy, and expulsion of the IUS. Expulsion is undesirable, because the IUS can no longer provide protection against pregnancy.
  • the most common side effect of copper IUD's is abnormal bleeding, taking the form of menorrhagia, metrorrhagia, or both. This side effect is not found with hormonal IUS's, which can be actually used for the treatment of menorrhagia.
  • a disparity between the size and/or shape of the uterine cavity and the IUS and inaccurate (non-fundal) placement of the system at the time of insertion have both been linked to IUS-induced increases in uterine bleeding.
  • the IUS In addition to the optimal design and composition, it is important that the IUS is placed in a proper position. For many complications, the examining physician must be able to detect the positioning and placement of the IUS in order to diagnose the problem, and to prevent further complications.
  • IUS's there are several techniques for determining the presence and position of IUS's in the uterus.
  • One technique involves the use of X-rays. However, the use of X-rays in the area of uterus and ovaries should be avoided whenever possible.
  • Another detection technique involves the use of sounds. Physicians also will often examine the marker strings, which are attached to the IUS to detect the presence and position of the IUS and at the end of usage time to remove the system.
  • Another technique is to manipulate the uterus under fluoroscopic examination. In some cases, a second IUS has been inserted into the uterus to serve as an intra-uterine marker to detect relative placement of the lost IUS.
  • Ultrasound imaging is widely used in medical applications to non-invasively observe the structures within the human body.
  • ultrasound imaging has also been employed to image medical devices that are inserted into tissue or passageways of the patient.
  • the uterus is visible to ultrasound by reconciling the position of the IUS with the position of the uterus.
  • the examining health care personnel can determine whether the IUS is properly placed within the uterus.
  • the medical personnel will be able to determine whether the IUS has perforated the uterus or cervix. If the IUS has partially or fully perforated the uterus or cervix, the physician, by knowing the position of the IUS is better able to plan an appropriate strategy for removal of the IUS.
  • a typical imaging system short bursts of ultrasound energy are directed into a patient's body with a transducer.
  • the returning reflected ultrasound energy, or echoes, are received by the same transducer and are converted to electrical signals.
  • the signals representing the reflected energy are processed and formatted into a video image of a target region.
  • the technology is especially valuable for medical imaging applications because diagnostic ultrasound procedures are safe, very acceptable to patients and less expensive than other digital imaging technologies. Also, instruments are widely available and images are produced in real time.
  • U.S. Pat. No. 5,201,314 describes a medical device that is insertable into tissue or a passageway and imageable with sonic imaging equipment.
  • the device includes an elongated insertable member that has an interface having a shape that is responsive to the sonic beam for producing the image.
  • the elongated member includes a sub-stance such as spherically or other geometrically-shaped particles that have a predetermined contour for establishing the interface. This contoured substance is contained within the material of the elongated member or alternatively or in combination attached to or embedded in the outside surface of the member material.
  • the interface layer may include a high density metal such as titanium, tungsten, barium, bismuth, platinum, silver, gold, or palladium.
  • U.S. Pat. No. 6,306,125 relates to a system for delivering an implant to tissue to be treated.
  • echogenic contrast agent can be added to the implant.
  • an implant can contain elements, molecules, compounds or compositions, which have atomic weights sufficient to confer radiopacity to the implant.
  • Particularly preferred radiopaque materials are, e.g. barium, gold, platinum, tantalum, bismuth and iodine.
  • the radiopacifying agents can be incorporated into the implants in several ways. Biocompatible non-immunogenic metals such as gold and platinum may be incorporated as a very fine dispersion with particle sizes less than a few micrometers. Other heavy atoms may be incorporated in the form of inorganic salts, such as barium sulphate.
  • U.S. Pat. No. 4,869,259 relates to the enhanced echogenicity of the needle by particle blasting with 50-micron particles to produce a uniformly roughened surface.
  • U.S. Pat. No. 4,977,897 relates to sounding apertures machined into needles to match the incident beam wavelength this improving sonographic visibility.
  • U.S. Pat. No. 5,289,831 relates to the modification of the catheters and other devices by incorporating glass spheres or high-density metal particles in the range of 0.5 to 100 microns or partially spherical indentations.
  • 5,327,891 relates to the use of microbubbles containing medium contained in vanes and/or tracks to echogenically enhance catheters.
  • U.S. Pat. No. 5,759,154 relates to the utilization of a masking technique to produce depressions comprising alternating rows of squares and diamonds on the surface around the circumference of the device.
  • the present invention thus provides an improved ultrasonically detectable intrauterine system (IUS) for relatively long-term insertion into a uterine cavity.
  • IUS intrauterine system
  • the IUS according to the invention comprises at least one image enhancing means for the ultrasound imaging of the system. Said means are selected from the group consisting of
  • an inert metal coating on at least part of the body of the intrauterine system b) at least one inert metal clip, pin, ring and/or sleeve fixedly positioned on the body of the intrauterine system; and c) a metallic loop anchored to the vertical arm of the body of the intrauterine system in place of the usual loop.
  • the invention is also directed to a method for improving the visualization of an intrauterine system within the uterine cavity in an ultrasound examination.
  • the method comprises i.a. the step of providing the body of an IUS with at least one inert metal clip, pin, ring and/or sleeve, applying an inert metal coating on at least part of the body of an IUS, or anchoring a metallic loop to the vertical arm of the body of an IUS.
  • the improvement of visibility of an IUS in an ultrasound examination has the advantage of enabling health care personnel to detect more easily the positioning of the device, thereby facilitating the detection of both problems in placement of the device and problems with the device itself.
  • Another advantage of this feature is that the positioning of the IUS can be ascertained without a physical intrusion into the area of the body wherein the device is inserted.
  • Transvaginal or abdominal ultrasound is nowadays a routine outpatient office procedure, which has almost completely displaced the use of X-ray examination in the detection of IUS's, in the ascertainment of the correct location of the device.
  • the ability to detect the IUS with ultrasound examination is of vital importance in various clinical situations, such as bleeding problems, pain, suspected expulsion (i.e. displacement of the IUS), or other possible adverse effects during IUS use.
  • the correct location is determined by ultrasound examination by measuring the distance between the upper end of the vertical stem of the system to the outer surface of the fundus of the uterus.
  • the use of ultrasound enables the ascertainment of the correct location of the IUS more accurately than an X-ray examination, e.g. in case of a partial expulsion of the device.
  • the use of X-rays should be strictly avoided in the general user population of IUS's, i.e. fertile aged women, to minimize the exposure of reproductive organs to X-rays.
  • the ovaries are very sensitive to the potential mutagenic effects of X-rays, whereas ultrasound examination does not carry any of such inherent risks.
  • the present invention enables the use of a safer and more reliable detection technique.
  • FIG. 1 A) Metal cored T-body on the left and reference IUS on the right. B) Surface modified T-body (with metal). Surface modification enhanced echogenicity of T-body remarkably. Views taken in in vitro medium with convex probe.
  • Normally 2-dimensional view is used in medical sector. Thus only horizontal arms (transverse view) or a vertical arm (sagital view) can be seen at a time with a convex probe ( FIG. 2A ). By a vaginal probe sometimes also a vertical arm can be seen ( FIG. 2B ).
  • FIG. 2 A) T-body, transverse view with convex-probe in water. The schematic model shows which part of T-body can be seen in the picture. B) T-body, view from the bottom of the T-body in water with vaginal probe (also vertical arm is visible).
  • FIG. 3 shows a comparative sagital view of the vertical arm of a regular hormonal IUS (on the left) and a hormonal IUS with metal (Au) coated T-body (on the right).
  • Convex probe in potato starch thickening It is known that especially the hormone capsule of an IUS fades out the echogenicity of the material underneath it. Au-coating improved the echogenicity of the T-body and the T-body is seen as bright image inside the hormone capsule.
  • FIG. 4 is a comparative sagital view of the vertical arm of a T-body with metal (Ag) rings in upper and lower part of the stem (A) with a regular T-body (B). Metal rings are seen as a bright echo behind the vertical arm. Vaginal probe in potato starch thickening.
  • FIG. 5 Optimal positions of echogenic enhancers: Echogenicity of place A or places A-B are the most important in order to locate the distance of IUS from fundus. In order to properly outline the position of horizontal arms in uterus, echogenicity of positions C-D is important.
  • FIG. 6 A hormonal contraceptive with Au-coated T-body.
  • FIG. 7 A) Unembedded Ag-rings at the upper and lower end of vertical arm of a hormonal IUS. B) Embedded double-rings at the upper and lower end of the vertical arm of a hormonal IUS.
  • FIG. 8 Acoustic shadowing behind the horizontal arms of MIRENA®. Note triple shadowing from the thickest parts of horizontal arms.
  • MIRENA® is a levonorgestrel-releasing intrauterine system (IUS), which consists of a hormoneelastomer capsule, mounted on a T-body and covered with an opaque tubing, which regulates the release of levonorgestrel.
  • IUS intrauterine system
  • FIG. 9 Comparison of a glass microsphere modified 7-frame with a standard T-frame in corn starch thickening by vaginal probe. The whole horizontal arm of the 7-frame is visible whereas only the three thickest parts of the T-frame and their acoustic shadowing can be seen.
  • FIG. 10 Spherical ends of Au-coated T-body (marked with arrows) were located from a sponge-water system.
  • FIG. 11 A comparative picture about the brightness of Ag-rings on the vertical arm (transverse view, vaginal probe).
  • FIG. 12 T-body design with positions for embedded metal rings at the ends of a vertical arm.
  • FIG. 13 A schematic picture of different loop designs together with T-body design for metals clips at the ends of a vertical arm.
  • Ultrasound visibility or echogenicity of an intrauterine device depends on the density difference of the adjacent materials, the propagation speed difference of sound in the adjacent materials, surface roughness, and the echogenicity of surrounding materials.
  • the ultrasound visibility of different material modifications of IUS's can be estimated by evaluating the echogenicity of the material from the calculated reflected energies.
  • Reflected energy R can be calculated from the acoustic impedances of adjacent materials (Z 1 and Z 2 ):
  • An intrauterine system comprises at least one image enhancing means for improving the ultrasound imaging of the system.
  • the means are selected from the group consisting of
  • an inert metal coating on at least part of the body of the intrauterine system b) at least one inert metal clip, pin, ring and/or sleeve fixedly positioned on the body of the intrauterine system, and c) an inert metallic loop anchored to the vertical arm of the body of the intrauterine system in place of the usual loop.
  • the metal is advantageously selected so that the reflected energy at the boundary of adjacent materials is as high as possible.
  • the metal is selected from the group consisting of inert metals, such as silver, gold, titanium, tungsten, barium, bismuth, platinum and palladium.
  • Preferred metals are silver, gold, titanium and platinum, which are known to be compatible (i.e. physically inert) with the human body.
  • copper may also be used.
  • the metal coating or the metal clips, pins, rings or sleeves are located at the ends of the vertical arm(s) of the IUS having the shape of the letter T or 7 . This enables a physician to reliably measure the distance of IUS from fundus. It is also possible to coat the “loop” at the end of the vertical arm of the IUS, or to fix a metal ring, pin or sleeve at the foot of the loop. In a further preferred embodiment, the metal coating or the metal clip, pin, ring or sleeve is located only at the “upper” end of the vertical arm of the IUS.
  • the thickness of the metal coating may vary from between about 0.1 nm and about 500 nm, preferably between about 1 nm and about 50 nm. However, even thicker coatings of about 0.1 mm are possible.
  • the metal clips, pins, rings or sleeves may be unembedded or at least partly embedded in the body of an IUS. Partial embedding of the rings smooths the surface of the IUS while not yet impairing the visibility compared to unembedded counterpart. In case of rings it is advantageous to use double rings to enhance echogenicity. In case of clips and sleeves, the broader the clip or sleeve, the better is the visibility.
  • the width of the metal clip, pin, ring or sleeve may vary for example from 0.2 to few millimetres, being preferably about 1 mm, or in case of double rings about 0.5 mm
  • a further embodiment is to fix a metal pin of an appropriate size through the loop, so that the ends of the pin which are larger than the diameter of the loop are visible.
  • the intrauterine system according to the invention may also have locking means, typically at least two locking parts, between which the medicated capsule is mounted.
  • the locking parts keep the capsule in the correct position during the insertion, use and removal of the IUS.
  • Said locking parts may have different shapes, e.g. a shape of a truncated cone. They can be made of a polymeric material, which can be the same or different from the material of the body, but other materials can also be used, for example in this case an inert metal which improves visibility of the IUS in an ultrasound examination.
  • the intrauterine system according to the invention has been designed for a relatively long-term insertion into a uterine cavity.
  • a long-term insertion may vary greatly, for example from a couple of weeks to several years, the maximum IUS usage time being typically up to five years.
  • the invention is also directed to a method for improving the visualization of an intrauterine system within the uterine cavity in an ultrasound examination, comprising at least one of the steps of

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Surgical Instruments (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
US11/887,901 2005-04-05 2006-04-04 Ultrasonically Detectable Intrauterine System and a Method for Enhancing Ultrasound Detection Abandoned US20090056723A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20050345A FI123188B (fi) 2005-04-05 2005-04-05 Ultraäänellä havaittavissa oleva kohdunsisäinen järjestelmä
FI20050345 2005-04-05
PCT/FI2006/050123 WO2006106180A1 (fr) 2005-04-05 2006-04-04 Systeme intra-uterin detectable par ultrasons et procede destine a intensifier la detection par les ultrasons

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI2006/050123 A-371-Of-International WO2006106180A1 (fr) 2005-04-05 2006-04-04 Systeme intra-uterin detectable par ultrasons et procede destine a intensifier la detection par les ultrasons

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/569,616 Continuation US11628088B2 (en) 2005-04-05 2014-12-12 Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection

Publications (1)

Publication Number Publication Date
US20090056723A1 true US20090056723A1 (en) 2009-03-05

Family

ID=34508050

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/887,901 Abandoned US20090056723A1 (en) 2005-04-05 2006-04-04 Ultrasonically Detectable Intrauterine System and a Method for Enhancing Ultrasound Detection
US14/569,616 Active 2027-02-07 US11628088B2 (en) 2005-04-05 2014-12-12 Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection
US17/534,114 Pending US20220160538A1 (en) 2005-04-05 2021-11-23 Ultrasonically detectable intrauterine system and method for enhancing ultrasound detection

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/569,616 Active 2027-02-07 US11628088B2 (en) 2005-04-05 2014-12-12 Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection
US17/534,114 Pending US20220160538A1 (en) 2005-04-05 2021-11-23 Ultrasonically detectable intrauterine system and method for enhancing ultrasound detection

Country Status (28)

Country Link
US (3) US20090056723A1 (fr)
EP (1) EP1871314B1 (fr)
JP (1) JP5264475B2 (fr)
KR (1) KR101264883B1 (fr)
CN (1) CN101188988A (fr)
AU (1) AU2006231212B2 (fr)
BR (1) BRPI0612196B1 (fr)
CA (1) CA2607079C (fr)
CR (1) CR9402A (fr)
CY (1) CY1120992T1 (fr)
DK (1) DK1871314T3 (fr)
EC (1) ECSP077804A (fr)
ES (1) ES2699162T3 (fr)
FI (1) FI123188B (fr)
HR (1) HRP20181826T1 (fr)
IL (1) IL186244A (fr)
LT (1) LT1871314T (fr)
MX (1) MX2007011820A (fr)
NO (1) NO339210B1 (fr)
NZ (1) NZ561952A (fr)
PL (1) PL1871314T3 (fr)
PT (1) PT1871314T (fr)
RS (1) RS57979B1 (fr)
RU (1) RU2389451C2 (fr)
SI (1) SI1871314T1 (fr)
UA (1) UA92606C2 (fr)
WO (1) WO2006106180A1 (fr)
ZA (1) ZA200709012B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170281400A1 (en) * 2014-08-28 2017-10-05 Caballus Carniolus & Amsterdamus, Veterinarsko Tehnoloski Center In Trgovina, Uvoz-Izvoz D.O.O. Insert for humans and animals and the process for producing the same

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20085277A0 (fi) * 2008-04-02 2008-04-02 Bayer Schering Pharma Oy Kohdunsisäinen järjestelmä
EP2140860A1 (fr) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy Procédé de contraception amélioré
RU2555389C2 (ru) * 2009-12-21 2015-07-10 ПАТ&Ко бвба Усовершенствование в бескаркасных внутриматочных устройствах и системах
RU2556569C1 (ru) * 2011-05-06 2015-07-10 В.Л. Гор Энд Ассошиейтс, Инк. Устройство с повышенной эхогенностью
EP2848202A1 (fr) * 2011-05-06 2015-03-18 W.L. Gore & Associates, Inc. Manchon échogénique
CN107356673B (zh) * 2017-08-10 2024-01-30 长江地球物理探测（武汉）有限公司 一种使用增强锚杆底端反射信号装置的无损检测方法
RU2763819C1 (ru) * 2021-06-25 2022-01-11 Разин Мирзекеримович Рагимов Способ улучшения эхогенных свойств игл для прицельной пункционной и аспирационной биопсии

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230953A (en) * 1963-01-30 1966-01-25 Charles H Birnberg Intrauterine device
US3515132A (en) * 1967-12-26 1970-06-02 Mcknight Charles A Intrauterine contraceptive device
US3633574A (en) * 1968-11-14 1972-01-11 Robins Co Inc A H Intrauterine contraceptive device
US3777748A (en) * 1969-06-25 1973-12-11 Searle & Co Intrauterine contraceptive devices and inserters therefor
US3811435A (en) * 1968-03-18 1974-05-21 S Soichet Intrauterine device and injection mechanism
US3913573A (en) * 1972-10-02 1975-10-21 Morton Gutnick Intrauterine contraceptive devices with plural parallel leg segments
US3935860A (en) * 1974-08-21 1976-02-03 Alza Corporation Intrauterine device with restrictor for maintaining device in uterine cavity
US4034749A (en) * 1973-12-06 1977-07-12 Schering Aktiengesellschaft Intrauterine contraceptive device
US4658810A (en) * 1982-07-31 1987-04-21 Bauer Hans A Method of contraception and a device therefor
US4807610A (en) * 1987-09-08 1989-02-28 Nauchno-Proizvodstvennoe Objedinenie "Medinstrument" Intrauterine contraceptive device
US5201314A (en) * 1989-03-09 1993-04-13 Vance Products Incorporated Echogenic devices, material and method
US20060016451A1 (en) * 2002-09-18 2006-01-26 Esa Hallinen Delivery sysem and a manufacturing process of a delivery system

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3533406A (en) * 1968-09-18 1970-10-13 Population Council Inc Intrauterine contraceptive device
DE2207939A1 (de) * 1972-02-15 1972-08-30 Schering Ag Intrauterines kontrazeptionsmittel
US4102998A (en) * 1972-10-02 1978-07-25 Morton Gutnick Process for the prevention of venereal disease
GB1465684A (en) * 1973-07-27 1977-02-23 Emmett L Contraceptive device
US3993058A (en) * 1974-08-21 1976-11-23 Alza Corporation Intrauterine device with seeker for finding the cervical os and housing member for fitting device in an inserter
FI820748L (fi) * 1981-03-17 1982-09-18 Banson Enterprises Inc I livmodern insaettbart preventivmedel och foerfarande foer framstaellning av detsamma
FR2517539A1 (fr) * 1981-12-03 1983-06-10 Deuil Jacques Dispositif intra-uterin
CS232807B1 (en) * 1982-05-04 1985-02-14 Valter Jakubek Inter-uterus anticonception little body and method of its making
EP0147274A1 (fr) * 1983-12-01 1985-07-03 BIOMASYS Société dite: Perfectionnements apportés aux dispositifs intra-utérins
US4869259A (en) 1988-05-17 1989-09-26 Vance Products Incorporated Echogenically enhanced surgical instrument and method for production thereof
US4977897A (en) 1988-08-17 1990-12-18 Robert Hurwitz Amniocentesis needle with improved sonographic visibility
HU200905B (en) 1989-02-07 1990-09-28 Radelkis Electrokemiai Electrochemical contraceptive device
US5289831A (en) 1989-03-09 1994-03-01 Vance Products Incorporated Surface-treated stent, catheter, cannula, and the like
FI84017B (fi) * 1990-03-16 1991-06-28 Kms Myynti Om Kerstin Margaret Foerfarande foer framstaellning av intranterina preventivmedel.
US5327891A (en) 1992-07-30 1994-07-12 Rammler David H Catheter track and catheter for diagnosis and treatment
NL9400410A (nl) * 1994-03-16 1995-11-01 M D Ph D Willem Arthur Adriaan Intra-uterine anticonceptiemiddel.
US6705323B1 (en) * 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US5759154A (en) 1996-12-23 1998-06-02 C. R. Bard, Inc. Print mask technique for echogenic enhancement of a medical device
FR2769828B1 (fr) * 1997-10-22 2000-03-17 7 Med 97 Sarl Societe D Etudes Dispositif anticonceptionnel intrauterin combine a son systeme d'insertion
CA2335058A1 (fr) 1998-06-22 1999-12-29 Danforth Joslyn Methode, implant et systeme de liberation utilises pour accroitre le debit sanguin dans les tissus
BE1012671A3 (fr) * 1999-05-07 2001-02-06 Wildemeersch Dirk Dispositif intra-uterin a efficacite accrue et a effets secondaires reduits.
US6708056B2 (en) * 2000-04-25 2004-03-16 Impres Medical, Inc. Method and apparatus for creating intrauterine adhesions
RU2164790C1 (ru) * 2000-05-10 2001-04-10 Чувашский государственный университет им. И.Н. Ульянова Устройство для внутриматочной контрацепции
WO2009009158A2 (fr) 2007-03-21 2009-01-15 Dow Global Technologies, Inc. Production métathétique de polymères fonctionnalisés

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230953A (en) * 1963-01-30 1966-01-25 Charles H Birnberg Intrauterine device
US3515132A (en) * 1967-12-26 1970-06-02 Mcknight Charles A Intrauterine contraceptive device
US3811435A (en) * 1968-03-18 1974-05-21 S Soichet Intrauterine device and injection mechanism
US3633574A (en) * 1968-11-14 1972-01-11 Robins Co Inc A H Intrauterine contraceptive device
US3777748A (en) * 1969-06-25 1973-12-11 Searle & Co Intrauterine contraceptive devices and inserters therefor
US3913573A (en) * 1972-10-02 1975-10-21 Morton Gutnick Intrauterine contraceptive devices with plural parallel leg segments
US4034749A (en) * 1973-12-06 1977-07-12 Schering Aktiengesellschaft Intrauterine contraceptive device
US3935860A (en) * 1974-08-21 1976-02-03 Alza Corporation Intrauterine device with restrictor for maintaining device in uterine cavity
US4658810A (en) * 1982-07-31 1987-04-21 Bauer Hans A Method of contraception and a device therefor
US4807610A (en) * 1987-09-08 1989-02-28 Nauchno-Proizvodstvennoe Objedinenie "Medinstrument" Intrauterine contraceptive device
US5201314A (en) * 1989-03-09 1993-04-13 Vance Products Incorporated Echogenic devices, material and method
US20060016451A1 (en) * 2002-09-18 2006-01-26 Esa Hallinen Delivery sysem and a manufacturing process of a delivery system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170281400A1 (en) * 2014-08-28 2017-10-05 Caballus Carniolus & Amsterdamus, Veterinarsko Tehnoloski Center In Trgovina, Uvoz-Izvoz D.O.O. Insert for humans and animals and the process for producing the same

Also Published As

Publication number Publication date
AU2006231212B2 (en) 2011-10-06
CA2607079A1 (fr) 2006-10-12
CR9402A (es) 2008-02-20
CN101188988A (zh) 2008-05-28
IL186244A (en) 2011-01-31
BRPI0612196B1 (pt) 2022-10-04
KR20070120542A (ko) 2007-12-24
MX2007011820A (es) 2008-01-22
JP5264475B2 (ja) 2013-08-14
ZA200709012B (en) 2009-01-28
US11628088B2 (en) 2023-04-18
PL1871314T3 (pl) 2019-03-29
EP1871314B1 (fr) 2018-10-03
US20150164684A1 (en) 2015-06-18
DK1871314T3 (en) 2018-12-10
PT1871314T (pt) 2018-12-03
UA92606C2 (ru) 2010-11-25
NO339210B1 (no) 2016-11-14
RU2007140994A (ru) 2009-05-20
EP1871314A1 (fr) 2008-01-02
AU2006231212A1 (en) 2006-10-12
WO2006106180A1 (fr) 2006-10-12
NZ561952A (en) 2011-06-30
RU2389451C2 (ru) 2010-05-20
HRP20181826T1 (hr) 2018-12-28
EP1871314A4 (fr) 2012-01-04
ECSP077804A (es) 2008-03-26
KR101264883B1 (ko) 2013-05-20
FI20050345A (fi) 2006-10-06
CY1120992T1 (el) 2019-12-11
CA2607079C (fr) 2015-02-17
FI123188B (fi) 2012-12-14
FI20050345A0 (fi) 2005-04-05
LT1871314T (lt) 2018-12-10
RS57979B1 (sr) 2019-01-31
BRPI0612196A2 (pt) 2010-10-26
ES2699162T3 (es) 2019-02-07
US20220160538A1 (en) 2022-05-26
NO20075597L (no) 2007-11-05
JP2008534197A (ja) 2008-08-28
SI1871314T1 (sl) 2019-01-31
IL186244A0 (en) 2008-01-20

Similar Documents

Publication Publication Date Title
US20220160538A1 (en) Ultrasonically detectable intrauterine system and method for enhancing ultrasound detection
US4805628A (en) Ultrasound contrast media for medically implantable and insertable devices
Cullinan et al. Sonohysterography: a technique for endometrial evaluation.
Hildebrandt et al. Ultrasonography of the urogenital tract in elephants (Loxodonta africana and Elephas maximus): an important tool for assessing female reproductive function
US20070191707A1 (en) Device for locating the cervix and uterus
Lantz et al. Ultrasound characteristics of subdermally implanted Implanon™ contraceptive rods
Caspi et al. Penetration of the bladder by a perforating intrauterine contraceptive device: a sonographic diagnosis
Callen et al. Intrauterine contraceptive devices: evaluation by sonography
Kikuchi et al. Intrauterine ultrasonography with a high-frequency probe: preliminary report
James jr et al. The use of diagnostic ultrasound in evaluation of the abdomen in primates with emphasis on the rhesus monkey (Macaca mulatta)
Hildebrandt Reproductive and diagnostic ultrasonography
Fonda et al. Ultrasound in Assisted Reproduction and Early Pregnancy: A Practical Guide
Lewin et al. Perineal echotomography and objective cervimetry
RU2150234C1 (ru) Способ диагностики гинекологических заболеваний у девочек и девушек при пороках развития гениталий
Radhakrishnan et al. Tips Chapter
Kupesic et al. Three-dimensional ultrasound in reproductive medicine
Kupesic et al. Three-dimensional ultrasound in the assessment of infertility
Reuter Critical uses of intraoperative gynecologic sonography.
Mathieu Lipiodol as a diagnostic aid: In fibromata of the female genital tract
Almström et al. Sonographic localization of an intramurally placed intratubal device—the P-block
Suresh et al. Evaluation of Fallopian Tube Infertility
Andrews PATHOLOGY OF THE UTERUS, CERVIX AND VAGINA
Serafini et al. 7 Sonohysterography in
Radhakrishnan et al. Tips and Tricks when Using Ultrasound in a Contraception Clinic
Kasi Visalakshi Evaluation of Efficacy of Sonosalphingogram for Assessing Tubal PatencyiIn Infertile Patients with Hysterosalphingogram as Gold Standard.

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAYER SCHERING PHARMA OY, FINLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TJADER, TAINA;HEINONEN, SARA;REEL/FRAME:020950/0157

Effective date: 20071010

AS Assignment

Owner name: BAYER OY, FINLAND

Free format text: CHANGE OF NAME;ASSIGNOR:BAYER SCHERING PHARMA OY;REEL/FRAME:027747/0462

Effective date: 20101231

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION